Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Evaluation of SBRT in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SBRT

NCT02816983 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02816983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Evaluation of SBRT in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SBRT
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
January 20, 2022
Enrollment
89 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer